Non-Toxic Drug Silences Incurable Brain Cancer Gene
Thursday, October 31, 2013 - 07:20
in Health & Medicine
Glioblastoma multiforme (GBM) is a brain cancer that kills approximately 13,000 Americans a year. It is aggressive and incurable. A research team has demonstrated delivery of a therapeutic delivered using nanotechnology that turns off a critical gene in this complex cancer, increasing survival rates significantly - in animals. The drug is designed to target a specific cancer-causing gene in cells. The drug simply flips the switch of the troublesome oncogene to "off," silencing the gene, which knocks out the proteins that keep cancer cells immortal. read more